Substance P binding to peripheral blood mononuclear leukocytes in atopic dermatitis

Acta Dermato-Venereologica

Volumn 77, Issue 4, 1997, Pages 260-263

  Ostlere, L S ^a,c   Gordon, D J ^a   Ayliffe, M J ^a   Rustin, M H A ^b   Pereira, R S ^a   Holden, C A ^a  

^a EPSOM AND ST HELIER UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Flow cytometry; Fluoresceinated substance P; Mononuclear cell leukocyte subsets

Indexed keywords

SUBSTANCE P;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; LYMPHOCYTE SUBPOPULATION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PSORIASIS;

ADOLESCENT; ADULT; DERMATITIS, ATOPIC; FEMALE; FLOW CYTOMETRY; FLUORESCEIN; FLUORESCEINS; HUMANS; LYMPHOCYTE SUBSETS; LYMPHOCYTES; MALE; MIDDLE AGED; PHYCOERYTHRIN; PROTEIN BINDING; PSORIASIS; SUBSTANCE P;

EID: 0030851467     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Singh V. Immunoregulatory role of neuropeptides. Progress in Drug Research 1992; 38: 149-169.
2. Metwali A, Blum AM, Ferraris L, Klein JS, Fiocchi C, Weinstock JV. Eosinophils within the healthy or inflamed human intestine produce substance P and vasoactive intestinal peptide. J Neuroimmunol 1994; 52: 69 78.
3. Coulson IH, Holden CA. Cutaneous reactions to substance P and histamine in atopic dermatitis. Br J Dermatol 1990; 122: 343-349.
4. Ebertz JM, Hirshman CA, Kettelkamp NS, Uno H, Hanifin JM. Substance P-induced histamine release in human cutaneous mast cells. J Invest Dermatol 1987; 88: 682-685.
5. Payan DG, Brewster DR, Goetzl EJ. Specific stimulation of human T lymphocytes by substance P. J Immunol 1983; 131: 1613-1615.
6. Kimata H, Yoshida A, Fujimoto M, Mikawa H. Effect of vasoactive intestinal peptide, somatostatin, and substance P on spontaneous IgE and IgG4 production in atopic patients. J Immunol 1993; 150: 4630-4640.
7. Hartung H-P, Wolters K, Toyka KV. Substance P: binding properties and studies on cellular responses in guinea pig macrophages. J Immunol 1986; 136: 3856-3863.
8. Marasco WA, Showell HJ, Becker EL. Substance P binds to the formylpeptide chemotaxis receptor on the rabbit neutrophil. Biochem Biophys Res Commun 1981; 99: 1065-1072.
9. Ruff M, Wahl S, Pert C. Substance P receptor-mediated chemotaxis of human monocytes. Peptides 1985; 6(Suppl 2):107-111.
10. Lotz M, Vaughan JH, Carson DA. Effects of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988; 241: 1218-1221.
11. Payan DG, Brewster DR, Missirian-Bastian A, Goetzl EJ. Substance P recognition by a subset of human T lymphocytes. J Clin Invest 1984; 74: 1532-1539.
12. Payan DG, Brewster DR, Goetzl EJ. Stereospecific receptors for substance P on cultured human IM-9 lymphoblasts. J Immunol 1984; 133: 3260-3265.
13. Pincelli C, Fantini F, Massimi P, Girolomoni G, Seidenari S, Giannetti A. Neuropeptides in the skin of patients with atopic dermatitis: an immunohistochemical study. Br J Dermatol 1990; 122: 745-750.
14. Tobin D, Nabarro G, de la Faille HB, van Vloten WA, van der Putte SCJ, Schuurman H-J. Increased numbers of immunoreactive nerve fibres in atopic dermatitis. J Allergy Clin Immunol 1992; 90: 613-622.
15. Ostlere LS, Cowen T, Rustin MHA. Neuropeptides in the skin of patients with atopic dermatitis. Clin Exp Dermatol 1995; 20: 462-467.
16. Wallengren J, Ekman R, Möller H. Substance P and vasoactive intestinal peptide in bullous and inflammatory skin disease. Acta Derm Venereol (Stockh) 1986; 66: 23-28.
17. Anand P, Springall DR, Blank MA, Sellu D, Polak JM, Bloom SR. Neuropeptides in skin disease: increased VIP in eczema and psoriasis but not axillary hyperhidrosis. Br J Dermatol 1991; 124: 547-549.
18. Zachary C, Allen M, MacDonald D. In situ quantification of T-lymphocyte subsets and Langerhans cells in the inflammatory infiltrate of atopic dermatitis. Br J Dermatol 1985; 112: 149 156.
19. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994; 102: 128-137.
20. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980; (Suppl)92: 44-47.
21. Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol (Stockh) 1989; (Suppl)144: 13-14.
22. Rangachari P, McWade D, Donoff B. Luminal tachykinin receptors on canine tracheal epithelium: functional subtyping. Regul Pept 1987; 18: 101-108.
23. Parnet P, Payan DG, Kerdelhué B, Mitsuhashi M. Neuroendocrine interaction on lymphocytes. Testosterone-induced modulation of the lymphocyte substance P receptor. J Neuroimmunol 1990; 28: 185-188.
24. Menkes CJ, Renoux M, Laoussadi S, Mauborgne A, Bruxelle J, Cesselin F. Substance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 1993; 20: 714-717.
25. Agro A, Stanisz AM. Are lymphocytes a target for substance P modulation in arthritis. Semin Arthritis Rheum 1992; 21: 252-258.
26. Braathen LR. T-cell subsets in patients with mild and severe atopic dermatitis. Acta Derm Venereol (Stockh) 1985; (Suppl)114: 133-136.
27. Faure MR, Nicolas JF, Thivolet J, Gaucherand MA, Czernielewski JM. Studies of T-cell subsets in atopic dermatitis: human T-cell subpopulations defined by specific monoclonal antibodies. Clin Immunol Immunopathol 1982; 22: 139-146.
28. Jensen JR. Reduction of active natural killer cells in patients with atopic dermatitis estimated at the single cell level. Acta Derm Venereol (Stockh) 1985; (Suppl)114: 105-108.
29. Lever RS, Lesko MJ, MacKie RM. Natural killer cell activity in atopic dermatitis: a sequential study. Clin Allergy 1985; 15: 479-486.
30. Croitoru K, Ernst PB, Bienenstock J, Padol I, Stanisz AM. Selective modulation of the natural killer activity of murine intestinal intraepithelial leucocytes by the neuropeptide substance P. Immunol 1990; 71: 196-201.
31. Lanier LL, Le AM, Phillips JH, Warner NL, Babcock GF. Subpopulations of human natural killer cells defined by expression of the leu-7 (HNK-1) and leu-11 (NK-15) antigens. J Immunol 1983; 131: 1789-1796.
32. Müller KM, Röcken M, Carlberg C, Hauser C. The induction and functions of murine T-helper cell subsets. J Invest Dermatol 1995; 105(Suppl 1):8S-13S.
33. Paliard X, de Waal Malefijt R, Yssel H, Blanchard D, Chretien I, Abrams J, et al. Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones. J Immunol 1988; 141: 849-855.
34. Tang M, Varigos G, Kemp A. Reduced interferon-gamma secretion with increased interferon-gamma mRNA expression in atopic dermatitis: evidence for a post-transcriptional defect. Clin Exp Immunol 1994; 97: 483-490.
35. Ostlere LS, Mallett RB, Kaminski A, Kaminski ER, Pereira RS, Holden CAH. Gamma-interferon production in atopic dermatitis shows differential modification by phosphodiesterase and prostaglandin inhibition. Br J Dermatol 1995; 133: 1-5.